Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1.
暂无分享,去创建一个
Kathryn E. Hamilton | N. Stehouwer | Brianna M Busscher | Jordan L. Scott | Andrew M. Tidball | B. Looyenga | L. Louters | Grace N Johnecheck | Leesha K Gunnink | J. Rekman
[1] Xiaozhuo Chen,et al. Plant‐derived glucose transport inhibitors with potential antitumor activity , 2019, Phytotherapy research : PTR.
[2] H. Waldmann,et al. Small‐Molecule Inhibition of Glucose Transporters GLUT‐1–4 , 2019, Chembiochem : a European journal of chemical biology.
[3] X. Fang,et al. Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876 , 2018, Cancers.
[4] Min Young Kim,et al. Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase , 2018, Anatomy & cell biology.
[5] F. Martel,et al. Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and Metabolism , 2018, Front. Nutr..
[6] S. Awasthi,et al. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. , 2018, Cancer letters.
[7] A. Godwin,et al. The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review , 2017, International journal of molecular sciences.
[8] T. Yi,et al. The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity , 2017, Oxidative medicine and cellular longevity.
[9] R. Rahimi,et al. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer , 2017, Journal of Gastrointestinal Cancer.
[10] G. Williamson,et al. The role of polyphenols in modern nutrition , 2017, Nutrition bulletin.
[11] T. Bernardi,et al. Research Progress in the Modification of Quercetin Leading to Anticancer Agents , 2017, Molecules.
[12] Jeremy Wodarek,et al. Caffeine inhibition of GLUT1 is dependent on the activation state of the transporter. , 2017, Biochimie.
[13] E. Şengül,et al. Therapeutic effect of quercetin on renal function and tissue damage in the obesity induced rats. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[14] Binbin Xie,et al. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis , 2017, Oncotarget.
[15] P. Haddad,et al. The Antidiabetic Potential of Quercetin: Underlying Mechanisms. , 2017, Current medicinal chemistry.
[16] R. Naftalin. Faculty Opinions recommendation of Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876. , 2017 .
[17] A. Carruthers,et al. WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site* , 2016, The Journal of Biological Chemistry.
[18] K. Griffiths,et al. Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention , 2016, Diseases.
[19] Subramani Parasuraman,et al. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid , 2016, Pharmacognosy reviews.
[20] Kathryn E. Hamilton,et al. Curcumin directly inhibits the transport activity of GLUT1. , 2016, Biochimie.
[21] R. Ghiasvand,et al. Quercetin and ovarian cancer: An evaluation based on a systematic review , 2016, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[22] Eugenia G. Giannopoulou,et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH , 2015, Science.
[23] Jay M. Sage,et al. Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site. , 2015, American journal of physiology. Cell physiology.
[24] A. Green,et al. Curcumin is a direct inhibitor of glucose transport in adipocytes. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[25] L. Szablewski. Expression of glucose transporters in cancers. , 2013, Biochimica et biophysica acta.
[26] J. Vera,et al. Noncompetitive blocking of human GLUT1 hexose transporter by methylxanthines reveals an exofacial regulatory binding site. , 2012, American journal of physiology. Cell physiology.
[27] Shiyong Wu,et al. A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo , 2012, Molecular Cancer Therapeutics.
[28] K. Akagawa,et al. Syntaxin 1C, a soluble form of syntaxin, attenuates membrane recycling by destabilizing microtubules , 2012, Journal of Cell Science.
[29] M. V. Vander Heiden,et al. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.
[30] J. Vera,et al. Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins. , 2011, Biochemistry.
[31] R. Naftalin,et al. Quercetin-iron chelates are transported via glucose transporters. , 2011, Free radical biology & medicine.
[32] Kounosuke Watabe,et al. Metabolic genes in cancer: their roles in tumor progression and clinical implications. , 2010, Biochimica et biophysica acta.
[33] S. Devaskar,et al. Will the original glucose transporter isoform please stand up! , 2009, American journal of physiology. Endocrinology and metabolism.
[34] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[35] Richard J. Naftalin,et al. Docking Studies Show That D-Glucose and Quercetin Slide through the Transporter GLUT1* , 2006, Journal of Biological Chemistry.
[36] Tomás Perez-Acle,et al. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. , 2005, The Biochemical journal.
[37] J. Best,et al. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer , 2005, Journal of cellular physiology.
[38] J. Tamargo,et al. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. , 2004, Molecular pharmacology.
[39] G. F. Fuhrmann,et al. The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. , 2003, Chemico-biological interactions.
[40] W. Pardridge,et al. Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis‐acting regulatory element , 2002, Journal of neurochemistry.
[41] E. van Nood,et al. Flavonoids: a review of probable mechanisms of action and potential applications. , 2001, The American journal of clinical nutrition.
[42] J. Vera,et al. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. , 2001, Biochemistry.
[43] M. Levine,et al. Intracellular accumulation of ascorbic acid is inhibited by flavonoids via blocking of dehydroascorbic acid and ascorbic acid uptakes in HL-60, U937 and Jurkat cells. , 2000, The Journal of nutrition.
[44] S. Kong,et al. Inhibition of glucose uptake and suppression of glucose transporter 1 mRNA expression in L929 cells by tumour necrosis factor-alpha. , 1999, Life sciences.
[45] J. B. Park,et al. Flavonoids are potential inhibitors of glucose uptake in U937 cells. , 1999, Biochemical and biophysical research communications.
[46] M. Williams,et al. Effect of glucose deprivation of GLUT 1 expression in 3T3-L1 adipocytes. , 1993, The Journal of biological chemistry.
[47] A. Carruthers,et al. Inhibitions of sugar transport produced by ligands binding at opposite sides of the membrane. Evidence for simultaneous occupation of the carrier by maltose and cytochalasin B. , 1991, Biochemistry.
[48] Y. Ben-Neriah,et al. The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein family of stress-inducible proteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. M. Krupka,et al. Cytochalasin B and the kinetics of inhibition of biological transport: a case of asymmetric binding to the glucose carrier. , 1978, Biochimica et biophysica acta.
[50] D. Basketter,et al. Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors. , 1978, The Journal of physiology.
[51] G. F. Baker,et al. Asymmetry of the hexose transfer system in human erythrocytes. Experiments with non‐transportable inhibitors. , 1978, The Journal of physiology.
[52] G. Holman,et al. Evidence for two asymmetric conformational states in the human erythrocyte sugar-transport system. , 1975, The Biochemical journal.